Tag Archives: Into

Lured by high demand, Korean wholesaler smuggled Novo’s obesity drug Saxenda into China

Anti-obesity drug Saxenda has been one of Novo Nordisk’s key growth drivers lately—and apparently, a Korean wholesaler noticed. The pharmaceutical middleman allegedly smuggled the popular drug into China, where it’s not yet approved. Korean regulators are investigating the wholesaler for allegedly hawking Saxenda in China, Korea Biomedical Review reported, citing multiple sources. A Novo spokeswoman confirmed to FiercePharma… Read More: Lured by high demand, Korean wholesaler smuggled Novo’s obesity drug… »

NIH boosts BRAIN Initiative funding to expand study into opioids

The National Institutes of Health is making new investments into the BRAIN Initiative, which will include new studies of opioids. New funds of $ 220 million to support 200 new research awards have been awarded, bringing total 2018 program support to more than $ 400 million, which is 50 percent more than the amount spent… Read More: NIH boosts BRAIN Initiative funding to expand study into opioids »